Amathus Therapeutics

Amathus Therapeutics is a biopharmaceutical company and a leader in the field of organelle-specific chaperone small molecule modulators, which are involved in a variety of genetically defined diseases, including Parkinson's disease (PINK1) and polycystic kidney disease (ADPKD).